Tag: affordability

Pharma’s last stand

When certain drugmakers have nothing to say about the growing prescription drug cost crisis and no solutions to point to, they cry “price controls.” This is a master bait and switch. Continue reading

Posted in: Health Care Costs

Dear New York Times: The Public Deserves Greater Transparency With Drug Prices

In response to a recent op-ed in the New York Times about expanding access to hepatitis C treatment, AHIP EVP Dan Durham addressed the real issue putting medicines out of reach for patients – skyrocketing launch prices being charged by drug companies. Continue reading

Posted in: AHIP in the News, AHIP Letters

4 Takeaways from Today’s Hearing on Health Care Competition

This morning, AHIP’s Dan Durham offered testimony on how health plans across the country are operating in highly competitive regulatory environments where success is defined by their ability to deliver affordable coverage choices and ensure high-quality care. Continue reading

Posted in: AHIP Testimony, In Case You Missed It, Uncategorized

What’s really blocking access to hepatitis C treatment

Drugmakers continue to use their monopoly power to set ridiculously high prices for new drugs, forcing health plans and employers to start negotiations at a much higher price point than ever before. Continue reading

Posted in: Health Care Costs

Transparency and High-Value Health Care

As the following examples show, efforts to arm patients with reliable quality and cost data to shop wisely for health care services will have a meaningful impact on bending the current, unsustainable health care cost curve. Continue reading

Posted in: AHIP Studies and Reports, Health Care Costs

New issue brief on empowering consumers

Whether it’s a cost calculator or a mobile app, health plans provide consumers with a wide-range of tools that allow individuals to easily compare data on estimated costs of certain procedures and treatments as well as quality measures so they can make informed choices when selecting a provider or hospital. Continue reading

Posted in: AHIP Studies and Reports, Health Care Costs

Pharma’s Red Herring

Whenever drugmakers can’t come up with a sound argument against good policy, they roll out their time-tested “price controls” diversion. Please. Continue reading

Posted in: Cost Alert

The Seniors Behind the Numbers

The research shows 88 percent of seniors enrolled in Medicare Advantage are highly satisfied with their plan. And 88 percent of these enrollees are satisfied with preventive care coverage, compared with 75 percent of fee-for-service Medicare beneficiaries. But the seniors behind the numbers are what’s most important – the individuals who stand up each day to protect what matters most. Continue reading

Posted in: What They Are Saying

What do consumers really think about drug prices?

Echoing June’s Kaiser Health Tracking Poll, the latest survey again shows a large majority of consumers (72 percent) – especially those currently taking prescription drugs (77 percent) – say the cost of medical treatments is unreasonable. Continue reading

Posted in: Cost Alert, Health Care Costs

JAMA: Making the case for health plan networks

By partnering with high-performing hospitals and providers that meet standards for delivering quality, efficient health care, health plans make it possible for individuals and families to access the care they need at an affordable price. Continue reading

Posted in: Issue Alert